Transplant News and Research

RSS

Ambit Biosciences presents data from Phase 2 ACE study of quizartinib for treatment of AML

Ambit Biosciences Corporation announced today data from the Phase 2 ACE study of quizartinib (AC220), a FLT3 inhibitor, were featured in multiple presentations at the 18th Congress of the European Hematology Association in Stockholm, Sweden.

27 Jun 2013

Kiadis Pharma to receive innovation credit from AgentschapNL to conduct Phase II study for ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it will receive an innovation credit of up to €3 million from AgentschapNL, a division of the Dutch Ministry of Economic Affairs, to support the Phase II clinical development of Kiadis Pharma's lead pipeline product, ATIR™

26 Jun 2013

Transplant officials to consider changes in organ donation

The nation's organ transplant network will consider a controversial proposal Monday to overhaul the guidelines for an increasingly common form of organ donation.

25 Jun 2013

Mayo Clinic opens new C. difficile Clinic at Rochester campus

Clostridium difficile (C. difficile) has reached an epidemic state and is the most common infectious cause of diarrhea in hospitals. Health care providers are seeing increased severity and recurrence rates of the infection. In response, Mayo Clinic has opened a C. difficile Clinic at the Rochester campus.

25 Jun 2013

New study provides guidelines for stem cell transplantation in older MDS patients

A new study by an international team led by Dana-Farber Cancer Institute scientists provides the first statistically-based guidelines for determining whether a stem cell transplant is appropriate for older patients with myelodysplastic syndromes - the most common blood disorders in people over 60 years of age, and frequently a precursor for leukemia.

25 Jun 2013

Rebiotix receives FDA Fast Track designation for RBX2660 to treat patients with CDI

Rebiotix Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation for the investigation of RBX2660 (microbiota suspension), intended for the treatment of recurrent Clostridium difficile infection.

25 Jun 2013

Researchers provide new revelations about intricate pathways involved in turning on T cells

A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body's most important disease-fighting cells, and was published today in the prestigious scientific journal Nature.

24 Jun 2013

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

African-Americans with Medicaid as their primary insurance were less likely to receive a living kidney transplant (LKT) than patients with private insurance, according to a new study by researchers at Wake Forest Baptist Medical Center.

21 Jun 2013

Johns Hopkins student-built devices win two top awards in national contest

Johns Hopkins student-built devices—a blood clot detection system and a concealable, hands-free breast pump—have won two of the top three awards in a national contest that recognizes innovative biomedical engineering designs that have high commercial potential and social impact.

21 Jun 2013

Study suggests social media initiative may help boost organ donation rates

A new social media initiative helped to boost organ donor registration rates, according to a new study published in the American Journal of Transplantation. The findings suggest that social media might be an effective tool for tackling a variety of problems related to public health in which communication and education are essential.

18 Jun 2013

Certain gastrointestinal types of GVHD are associated with worsened quality of life and death

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal and liver-related types of chronic graft-versus-host disease (GVHD) are associated with worsened quality of life and death.

18 Jun 2013

Early exposure to BPA increases risk for prostate cancer in human prostate tissue

Early exposure to BPA (bisphenol A) - an additive commonly found in plastic water bottles and soup can liners - causes an increased cancer risk in an animal model of human prostate cancer, according to University of Illinois at Chicago researcher Gail Prins.

18 Jun 2013

Investigators recruit subjects for Boston Children's Hand Transplant Program

Boston Children's Hospital today announced that investigators are now recruiting subjects for the world's first pediatric hand transplant program. The Boston Children's Hand Transplant Program, led by principal investigator Amir Taghinia, MD, and William Harmon, MD, is a research-based program that will offer bi-lateral hand transplants for children living without two functioning hands.

17 Jun 2013

Researchers are one step closer to treating type 1 diabetes

Researchers at Washington University School of Medicine in St. Louis have identified a way to trigger reproduction in the laboratory of clusters of human cells that make insulin, potentially removing a significant obstacle to transplanting the cells as a treatment for patients with type 1 diabetes.

14 Jun 2013

Viewpoints: 'Tyranny' over insurers; Obama's promises; Rep. Franks's abortion claim

Many of us wish that Obamacare were a simpler system, one that directly provided health insurance. Political reality, unfortunately, ensured that many people will receive coverage from private insurers, selling policies - often with subsidies - on the "exchanges". And naturally enough, the Obama administration is teaming up with the insurers and other parts of the health industry to help inform Americans of the benefits to which they will be legally entitled, starting Jan. 1 (Paul Krugman, 6/12).

14 Jun 2013

Seven SynCardia Certified Centers ranked among nation's Best Children's Hospitals

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named seven SynCardia Certified Centers among the nation's "Best Children's Hospitals" for cardiology and heart surgery in its annual rankings for 2013-2014.

13 Jun 2013

Omeros gets regulatory clearance to begin Phase 1 clinical trial of OMS721

Omeros Corporation today announced that it has obtained regulatory clearance to start the Phase 1 clinical trial evaluating OMS721, the Company's lead human monoclonal antibody from its mannan-binding lectin-associated serine protease-2 (MASP-2) program.

13 Jun 2013

Organ transplant board calls for review of child policy, creates new appeal system

A panel of officials that decides matters on organ transplants called Monday for a review of the guidelines for issuing organs to children and created a special appeals process after two cases of children who need lung transplants drew congressional and judicial attention.

12 Jun 2013

Study reveals radioimmunotherapy can improve survival rates of patients with aggressive lymphoma

A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

12 Jun 2013

C.S. Mott Children's Hospital ranked among nation's best children's hospitals

The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals in the country in pediatric specialties and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2013-14 Best Children's Hospitals rankings.

12 Jun 2013

Transplant News and Research

Ambit Biosciences presents data from Phase 2 ACE study of quizartinib for treatment of AML

Kiadis Pharma to receive innovation credit from AgentschapNL to conduct Phase II study for ATIR

Transplant officials to consider changes in organ donation

Mayo Clinic opens new C. difficile Clinic at Rochester campus

New study provides guidelines for stem cell transplantation in older MDS patients

Rebiotix receives FDA Fast Track designation for RBX2660 to treat patients with CDI

Researchers provide new revelations about intricate pathways involved in turning on T cells

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

Johns Hopkins student-built devices win two top awards in national contest

Study suggests social media initiative may help boost organ donation rates

Certain gastrointestinal types of GVHD are associated with worsened quality of life and death

Early exposure to BPA increases risk for prostate cancer in human prostate tissue

Investigators recruit subjects for Boston Children's Hand Transplant Program

Researchers are one step closer to treating type 1 diabetes

Viewpoints: 'Tyranny' over insurers; Obama's promises; Rep. Franks's abortion claim

Seven SynCardia Certified Centers ranked among nation's Best Children's Hospitals

Omeros gets regulatory clearance to begin Phase 1 clinical trial of OMS721

Organ transplant board calls for review of child policy, creates new appeal system

Study reveals radioimmunotherapy can improve survival rates of patients with aggressive lymphoma

C.S. Mott Children's Hospital ranked among nation's best children's hospitals

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News